Abstract
Several reports indicate that intracellular levels of NAD are rapidly decreased by DNA-damaging agents such as strep-tozotocin1–7, neocarzinostatin8,9 and ionising radiation8–11. Similarly, evidence obtained from studies in isolated nuclei and permeabilised cells indicates that DNA damage caused by several alkylating chemicals12–15, X rays16,17 and DNA-hydrolysing enzymes18,19 elicit a considerable increase in the activity of poly(ADP-ribose) polymerase, a chromosomal enzyme which uses NAD as a substrate in the formation of poly(ADP-ribose) in histones and other nuclear proteins20,21. Thus, it has been suggested that DNA-damaging agents lower NAD levels by causing an increase in poly(ADP-ribose) synthesis9,12,13. As DNA damage initiates DNA repair mechanisms, it has also been argued that poly(ADP-ribose) is involved in DNA repair8,12,14,17,22,23. Such possibilities would be strongly supported if an actual increase in the intracellular levels of poly(ADP-ribose) could be shown to occur after induction of DNA damage. We now present data obtained using a new technique which has enabled us to measure the levels of poly(ADP-ribose) in vivo in SV40 virus-transformed 3T3 cells (SVT2). We show that treatment of these cells with the powerful mutagen N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) produces, concomitantly with a decrease in NAD levels, a dramatic increase in the intracellular levels of poly (ADP-ribose).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schein, P. S. & Loftus, S. Cancer Res. 28, 1501–1506 (1968).
Ho, C. K. & Hashim, S. A. Diabetes 21, 789–793 (1972).
Chang, A. Y. Biochim. biophys. Acta 261, 77–84 (1972).
Hinz, M., Katsilambros, N., Maier, V., Schatz, H. & Pfeiffer, E. F. FEBS Lett. 30, 225–228 (1973).
Schein, P. S., Cooney, D. A., McMenamin, M. G. & Anderson, T. Biochem. Pharmac. 22, 2625–2631 (1973).
Gunnarson, R., Berne, C. & Hellerstrom, C. Biochem. J. 140, 487–494 (1974).
Davies, M. I., Halldorsson, H., Shall, S. & Skidmore, C. J. Biochem. Soc. Trans. 4, 635–637 (1976).
Davies, M. I., Shall, S. & Skidmore, C. J. Biochem. Soc. Trans. 5, 949–950 (1977).
Goodwin, P. M., Lewis, P. J., Davies, M. I., Skidmore, C. J. & Shall, S. Biochim. biophys.Acta 543, 576–582 (1978).
Campagnari, F., Whitfield, J. F. & Bertazzoni, U. Expl Cell Res. 42, 646–656 (1966).
Hilz, H., Hlavica, P. & Bertram, B. Biochem. Z. 338, 283–299 (1963).
Smulson, M. E., Schein, P., Mullins, D. W. & Sudhakar, S. Cancer Res. 37, 3006–3012 (1977).
Sudhakar, S., Tew, K. D. & Smulson, M. E. Cancer Res. 39, 1405–1410 (1979).
Berger, N. A., Sikorski, G. W., Petzold, S. J. & Kurohara, K. K. Fedn Proc. 38, 619 (1979).
Jacobson, M. K. & Jacobson, E. L. J. supramolec. Struct. Suppl. 2, 74 (1978).
Benjamin, R. C. & Gill, D. M. J.supramolec. Struct. Suppl. 2, 74 (1978).
Benjamin, R. C. & Gill, D. M. Fedn Proc. 38, 619 (1979).
Miller, E. G. Biochem. biophys. Res. Commun. 66, 280–286 (1975).
Miller, E. G. Biochem. biophys. Acta 395, 191–200 (1975).
Hilz, H. & Stone, P. Rev. Physiol. Biochem. Pharmac. 76, 1–58 (1976).
Hayaishi, O. & Ueda, K. A. Rev. Biochem. 46, 95–116 (1977).
Davies, M. I., Halldorsson, H., Nduka, N., Shall, S. & Skidmore, C. J. Biochem. Soc. Trans. 6, 1056–1057 (1978).
Jacobson, E. L. & Narasimhan, G. Fedn Proc. 38, 619 (1979).
Barrio, J. R., Secrist, J. A. III & Leonard, N. J. Biochem. biophys. Res. Commun. 46, 597–604 (1972).
Magee, P. N., Montesano, R. & Preussman, R. in Chemical Carcinogens (ed. Searle, E. E.) (Am. chem. Soc. Monogr., Washington, 1976).
Lijinsky, W. Prog. Nucleic Acid Res. 17, 247–269 (1976).
Jacobson, E. L. & Jacobson, M. K. Archs Biochem. Biophys. 175, 627–634 (1976).
Cuatrecasas, P. J. biol. Chem. 245, 3059–3065 (1975).
Jacobson, E. L., Lange, R. A. & Jacobson, M. K. J. cell. Physiol. 99, 417–426 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Juarez-Salinas, H., Sims, J. & Jacobson, M. Poly(ADP-ribose) levels in carcinogen-treated cells. Nature 282, 740–741 (1979). https://doi.org/10.1038/282740a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/282740a0
This article is cited by
-
Ionizing radiation responses appear incidental to desiccation responses in the bdelloid rotifer Adineta vaga
BMC Biology (2024)
-
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nature Reviews Drug Discovery (2020)
-
Targeting DNA repair and replication stress in the treatment of ovarian cancer
International Journal of Clinical Oncology (2017)
-
PARP Inhibitors in Prostate Cancer
Current Treatment Options in Oncology (2017)
-
Single cell resolution in vivo imaging of DNA damage following PARP inhibition
Scientific Reports (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.